by TractManager | Jun 24, 2024 | Emerging Technology Report
Bulevirtide (Gilead Sciences Inc.) is an investigational, first-in-class, subcutaneously injected virion entry inhibitor proposed for the treatment of chronic hepatitis delta virus (HDV) infection in adults with compensated liver disease.
by TractManager | Jun 17, 2024 | Emerging Technology Report
The Nelli System (Neuro Event Labs) is an investigational video- and audio-based seizure detection system may be used in a healthcare facility or in a patient’s home.
by TractManager | Jun 17, 2024 | Emerging Technology Report
Etripamil is an investigational, self-administered, calcium-channel blocker, nasal spray for rapid termination of paroxysmal supraventricular tachycardia outside of the healthcare setting.
by TractManager | Jun 13, 2024 | Emerging Technology Report
The TriClip G4 System (Abbott Medical) is a transcatheter tricuspid valve repair system indicated for improving quality of life and functional status in patients with symptomatic severe tricuspid regurgitation despite optimal medical therapy, who are at intermediate...
by TractManager | Jun 12, 2024 | Emerging Technology Report
The Spinal Cord Neuromodulator (SCONE; SpineX Inc.) is an investigational device that delivers transcutaneous electrical stimulation. It is proposed for improving urinary incontinence symptoms in adults with neurogenic bladder due to spinal cord injury, multiple...
Recent Comments